Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Accelerated Approval Is For Patients, Not Sponsors – US FDA’s Pazdur
Dec 02 2022
•
By
Michael McCaughan
Richard Pazdur is policing the accelerated approval pathway on behalf of patients. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from Approval Standards
More from Pathways & Standards